Our findings identified the effects of CYT on identifying the potential regulatory with SRSF1/MYO1B axis via transcriptome analysis and experiment verification, supporting the anti-tumor effects of CYT against drug resistant breast cancer. Here, MYO1B is linked to breast carcinoma.